Donald A Denkhaus - Net Worth and Insider Trading
Donald A Denkhaus Net Worth
The estimated net worth of Donald A Denkhaus is at least $4 Million dollars as of 2024-05-12. Donald A Denkhaus is the Director of Catalyst Pharmaceuticals Inc and owns about 277,666 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $4 Million. Details can be seen in Donald A Denkhaus's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Donald A Denkhaus has not made any transactions after 2022-11-11 and currently still holds the listed stock(s).
Transaction Summary of Donald A Denkhaus
Donald A Denkhaus Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Donald A Denkhaus owns 1 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) .
Click here to see the complete history of Donald A Denkhaus’s form 4 insider trades.
Insider Ownership Summary of Donald A Denkhaus
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2022-11-11 | director |
Donald A Denkhaus Latest Holdings Summary
Donald A Denkhaus currently owns a total of 1 stock. Donald A Denkhaus owns 277,666 shares of Catalyst Pharmaceuticals Inc (CPRX) as of November 11, 2022, with a value of $4 Million.
Latest Holdings of Donald A Denkhaus
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2022-11-11 | 277,666 | 15.94 | 4,425,996 |
Holding Weightings of Donald A Denkhaus
Donald A Denkhaus Form 4 Trading Tracker
According to the SEC Form 4 filings, Donald A Denkhaus has made a total of 2 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 20,000 shares on November 11, 2022, which brought Donald A Denkhaus around $331,800.
Insider Trading History of Donald A Denkhaus
- 1
Donald A Denkhaus Trading Performance
GuruFocus tracks the stock performance after each of Donald A Denkhaus's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Donald A Denkhaus is 31.14%. GuruFocus also compares Donald A Denkhaus's trading performance to market benchmark return within the same time period. The performance of stocks bought by Donald A Denkhaus within 3 months outperforms 5 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Donald A Denkhaus's insider trading performs compared to the benchmark.
Performance of Donald A Denkhaus
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.22 | | | | | |
| Relative Return to S&P 500(%) | 3.05 | | | | | |
Donald A Denkhaus Ownership Network
Donald A Denkhaus Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
Donald A Denkhaus is the director of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include Chief Compliance/Legal Officer Brian Elsbernd , Chief Accounting Officer Alicia Grande , and Chief Medical Officer Gary Ingenito .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, Donald A Denkhaus made no insider transaction in Catalyst Pharmaceuticals Inc (CPRX). Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 430,000 shares made by Alicia Grande , a net sale of 105,000 shares made by David S Tierney , and a net sale of 526,151 shares made by Patrick J Mcenany .
In summary, during the past 3 months, insiders sold 50,000 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 50,000 shares. During the past 18 months, 1,574,054 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,574,054 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
Donald A Denkhaus Mailing Address
Above is the net worth, insider trading, and ownership report for Donald A Denkhaus. You might contact Donald A Denkhaus via mailing address: 355 Alhambra Circle, Suite 1500, Coral Gables Fl 33134.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
